Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
House Dust Mite Sublingual Drops for Atopic Dermatitis (Phase II)
CTR20131417Phase 2Completed
- Sponsor
- Wolwo Biotech
- Start
- Feb 2015
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of house dust mite sublingual drops in atopic dermatitis (AD) (6 arms), sponsored by Wolwo Biotech. Started Feb 2015; status: completed.
02
Drugs
house dust mite sublingual drops
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20131417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131417.